Home Biotech Stocks

Biotech Stocks

7 days popular

Teva Pharmaceutical Industries (NYSE:TEVA) Executive Yitzhak Peterburg Claims Health Care Industry...

ME Contributor - June 30, 2017

Novartis AG (ADR) (NYSE:NVS)’ Leukemia Drug Allowed Priority Review By The...

Andy Parker - March 31, 2017

AbbVie Inc (NYSE:ABBV) In Share Buyback Plan For The Third Year...

ME Contributor - February 21, 2017

Cannabis Space Continues to Shine As Latest IPO Therapix BioSciences (NASDAQ:TRPX)...

ME Contributor - March 22, 2017

VBL Therapeutics CEO tells us about their revolutionary approach to cure...

David Rich - September 16, 2016

EMA Reviews Regeneron Pharmaceuticals Inc (NASDAQ:REGN), Sanofi SA (ADR) (NYSE:SNY) Dupixent...

ME Contributor - December 9, 2016

AstraZeneca plc (ADR)(NYSE:AZN) Durvalumab Nabs Its First FDA Approval

ME Contributor - May 2, 2017

What are the Implications of Eli Lilly’s FDA Black Box?

Roger Hannington - November 27, 2015

Merck & Co., Inc. (NYSE:MRK) and OpGen Inc (NASDAQ:OPGN) Are Quietly...

ME Contributor - July 19, 2016

Biotech Movers: Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) and pSivida Corp. (NASDAQ:PSDV)

ME Contributor - June 14, 2017

12 3...146 Page 1 of 146

/* */

EDITOR PICKS

Market Morning: More OPEC Cuts, GM LG Battery Team-Up, Germany Sputters,...

December 5, 2019

Market Morning: Trade Deal Scuttled, French Cheese Wars, Gronk Picks CBD...

December 3, 2019

Market Morning: Grey Friday, Impossible Whopper Lawsuit, Apollo Wins Tech Data

December 1, 2019

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

April 11, 2016

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

April 8, 2016

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

November 8, 2017

ABOUT US

Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.